Zdrowie i gospodarka · 05/01/2016

FDA Reclassifies Surgical Mesh for Transvaginal Pelvic Organ Prolapse Repair

The Food and Drug Administration (FDA) is reclassifying surgical mesh for transvaginal pelvic organ prolapse repair from class II to class III, citing concerns over safety and effectiveness, and a potential unreasonable risk of illness or injury.